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NADH = Nicotinamide adenine dinucleotide (reduced form) 
NAD
+
 = Nicotinamide adenine dinucleotide 
NAD(P)H = Nicotinamide adenine dinucleotide phosphate (reduced form) 
 
Introduction 
The coenzymes NAD(P)
+
 and NAD(P)H play a crucial role in the redox machinery of living 
systems. This relates to their ability to either accept a hydride at the C4-position of the pyridine 
ring in their oxidized form or to donate the respective hydride in the reverse-reaction (Scheme 1). 
When the hydride is replaced by a deuteride in the reduction step, two diastereoisomers can be 
formed, due to the presence of the enantiopure adenine dinucleotide moiety. The 
diastereoisomers thus differ only in their configuration at C4. Stereoselective labelling of the 
coenzymes with deuterium or tritium yields precious mechanistic information for the 
corresponding enzymes. Methods for their preparation in high stereoisomeric purity are well 
established.
[1-3]
 
 
Scheme 1-Deuteration of NAD
+
 at the C4 position yields diastereoisomers. 
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 Biocatalysis gains an ever increasing share in modern chemical manufacture, boosted by 
powerful protein engineering strategies.
[4]
 NAD(P)H or NAD(P)
+
 mol quivalents are required in 
various biotransformations, including ketoreductases, alcohol dehydrogenases, Baeyer Villiger 
monooxygenases, imine reductases, and P450s.
[5-8]
 These co-substrates are typically regenerated 
enzymatically in a catalytic concurrent fashion.
[9]
 However, alternative approaches employing 
e.g. chemocatalysis or electrochemical reduction have received increasing attention since they 
offer additional flexibility in process conditions and are readily transferrable to NAD(P)-
mimicks, which are substantially cheaper than their natural analogues.
[10]
 
One complex which has been frequently used in non-enzymatic regeneration systems for the 
transfer of reducing equivalents to NAD(P)
+
 is the achiral [RhCp*(bipy)(H2O)]
2+
.
[11]
 At least one 
report exists where an enantiopure complex was utilized.
[12]
 However, no labelling studies were 
undertaken and accordingly, no diastereoselectivity for the reduction step studied. We recently 
reported on the application of an artificial transfer hydrogenase (ATHase) for the concurrent 
regeneration of NADH in a monooxygenase-coupled reaction.
[13]
 To generate the artificial 
metalloenzyme, a biotinylated iridium pianostool complex was incorporated into streptavidin-
mutant S112A (Figure 1). The biotinylated ligand for the IrCp* moiety is achiral in the vicinity of 
the metal center and the respective complex has been shown to induce only negligible 
stereocontrol in the reduction of prochiral imine substrates in the absence of streptavidin (Sav). 
However, upon incorporation into Sav, substantial stereocontrol can be achieved.
[14]
 Importantly, 
the concurrent process with the monooxygenase and other enzymes was only effective, when the 
complex was located inside Sav; otherwise dramatic deactivation of the monooxygenase and/or 
the artificial Ir-cofactor occurred.
[13]
     
We have previously shown that substrate reduction with ATHases derived from streptavidin 
mutants S112A and S112K lead to R- and S- enantiomers for both ketones and imines, 
respectively.
[14]
 The corresponding X-ray structures of [Cp*Ir(Biot-p-L)Cl]⊂ S112A
[14]
 and 
[Cp*Ir(Biot-p-L)Cl]⊂ S112K
[15]
 were recently reported and analysed: for S112A, the absolute 
configuration at [Cp*Ir(Biot-p-L)Cl] is (S) and for S112K, the absolute configuration is (R). 
Based on modeling studies, we hypothesise that the absolute configuration at Ir by-and-large 
determines the absolute configuration of the alcohol and amine products: we term this 
phenomenon “induced lock-and-key” whereby the protein determines the configuration of the 
metal which in turn dictates which prochiral face of the substrate is reduced.
[15]
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 Here we report on the diastereoselectivity of NAD deuteration employing the Ir-cofactor by itself 
and upon incorporation into two Sav-mutants (Figure 1).  
   
Figure 1- NAD
+
 reduction, a) with a biotinylated Ir-complex and deuterated sodium formate in the absence of 
streptavidin mutants proceeds with low diastereoselectivity. b) Upon incorporation into streptavidin mutants, the 
reduction proceeds with high diastereoselectivity. The star symbolizes a mutation in streptavidin.  
 
Results and Discussion 
To determine the diastereomeric ratio after reduction with deuteride, 
1
H-NMR-spectroscopy 
offers a convenient means.
[16, 17]
 This technique enables the direct determination of the 
diastereoselectivity in the reaction mixture without requiring isolation of the products. The only 
noteworthy differences to potential preparative reactions lie in the presence of a small amount of 
deuterium oxide (5 %), the dissolution of the biotinylated Ir-complex in DMF-d7 instead of DMF 
and a short centrifugation step. Based on catalysis results obtained in asymmetric imine 
reduction
[14]
 and NADH regeneration
[13]
 with artificial metalloenzymes, the selectivity with two 
representative mutants was investigated. Mutant S112A, employed previously for concurrent 
NADH regeneration, leads to superior enantiomeric excess and high turnover numbers in the 
reduction of 1-methyl-6,7-dimethoxy-3,4-tetrahydroisoquinoline yielding (R)-configured 
salsolidine (up to 96 % ee).
[14]
 Reduction of the same substrate with the AME based on S112K, in 
contrast, leads to a bias in favour of the (S)-enantiomer (up to 78 % ee).
[14]
  
For the stereoselective NAD
+
 reduction experiments, deuterated sodium formate was used as a 
deuteride source in the presence of [Cp*Ir(biot-p-L)Cl]·S112A Sav and NAD
+
. Following 
centrifugation, the crude reaction mixtures were analyzed by 
1
H-NMR spectroscopy. While 
background signals of the protein and other components of the crude reaction mixture prevented 
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unambiguous integration of 1D 
1
H-NMR data, a selective one-dimensional TOCSY NMR 
experiment using irradiation on H6 (5.89 ppm) yielded clean spectra with sufficient signal to 
noise ratio to reliably integrate the two resonances attributed to both diastereomers (Figure 1). As 
the TOCSY transfer occurs with slightly different efficiency for (4R-
2
H)-NADH and (4S-
2
H)-
NADH, a calibration TOCSY experiment with commercial, non-deuterated NADH was 
performed (Figure 4a) and the resulting integrals (1.00 : 1.13 for H4S : H4R) were used to 
normalize the integrals of the deuterated species (Figure 1b-d). Due to the collapse of the 
2
JHH 
coupling constant of 18.1 Hz into a 
2
JHD of 2.8 Hz, both H4 resonances appear as broad singlets 
in the TOCSY spectrum and the fine structure is lost. The integration yielded a de of 87% for 
mutant S112A and a de of 90% for mutant S112K, while a de of 38% was obtained for the 
sample without Sav (all with an error margin of  +/– 1%), after 16 hours reaction time (Figure 2). 
The modest, but significant diastereoselectivity observed in the absence of Sav, arises most likely 
from substrate control considering the formation of basically racemic product from achiral 
starting materials in related transformations.
[13, 14]
 Both mutants led to a significant improvement 
in the diastereomeric excess compared to the result obtained in the absence of streptavidin 
(Figure 2). 
Interestingly, for the NAD
+
 reduction, both S112A and S112K ATHases afford the same 
diastereomer preferentially. This observation stands in stark contrast with results previously 
reported for ketone and imine reduction whereby S112A and S112K afford (R)- and (S)-reduction 
products respectively. In a matched-mismatched spirit, we speculate that the inherent chirality of 
the sugar moiety of NAD
+
 counterbalances the ATHase preference. This is supported by the 
inherent preference of the substrate in the absence of Sav. Alternatively, one NAD
+
 substrate 
could bind in the biotin vestibule in S112A, thus modifying the environment of the metal 
complex. Similar results were computed for the imine reductase with S112A.
[15]
 The preparation 
and screening of further mutants might provide guiding answers towards the design of ATHases 
with inverted selectivities for the reduction of NAD
+
. 
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Figure 2- Selected region from selective 
1
H-TOCSY spectra of a) commercial NADH, and catalytic reduction of 
NAD
+
 using 
2
HCOONa with, b) S112A; c) S112K; d) no Sav.  
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Conclusions 
The high chiral induction observed is promising for further applications such as the investigation 
of specificity in enzymes utilizing NAD(P)-mimicks and the resulting information would be of 
interest for future enzyme engineering tasks. Furthermore, related prochiral structures can be 
envisaged, namely 3,4 substituted pyridinium ions, which would provide valuable building 
blocks upon asymmetric conversion.
[17]
 
 
Experimental part 
Nicotinamide adenine dinucleotide hydrate (NAD
+
, contains 10 % H2O) was purchased from 
Sigma. 
2
HCOONa was purchased from ABCR. Streptavidin was prepared as previously 
reported.
[13]
 [Cp*Ir(biot-p-L)Cl] was a kind gift from M. Dürrenberger and prepared as reported 
in reference.
[19]
 NMR experiments were performed at 25°C (MeOH calibration) on a Bruker 
Avance III NMR spectrometer operating at 600 MHz proton frequency, equipped with a direct 
detection dual channel, broadband probe-head with z-gradient. Chemical shifts were referenced 
against proton solvent peaks (4.773 ppm for H2O). The selective TOCSY experiment
[20, 21]
 was 
performed using a MLEV17 spinlock sequence with a mixing time of 120 ms, trim pulses of 2.5 
ms and a selective Gauss shaped refocusing pulse of 80 ms duration.  
Stock solutions: buffer 1: sodium phosphate 50 mM, pH 7.5; buffer 2: 
2
HCOONa 200 mM, 
sodium phosphate, pH 7.5 (
2
HCOONa (138 mg) was dissolved in H2O (5 ml), sodium phosphate 
buffer (0.5 ml, 1M) was added and the pH adjusted to 7.5 by addition of aq. NaH2PO4. Water was 
added to a total volume of 10 ml); NAD
+
 stock solution: 10 mM in buffer 1 (NAD
+
 (29.9 mg, 405 
µmol) was dissolved in buffer 1 (4.05 ml); Ir-stock solution: 10 mM [Cp*Ir(biot-p-L)Cl] (2.55 
mg, 3.17 µmol) was dissolved in DMF-d7 (317 µl). 
Preparation of ATHase: Sav-mutant S112A (2.53 mg, assuming 3 free binding sites) was 
dissolved in buffer 1 (1.144 mL), and Ir-stock solution was added (11.6 µl).  
Sav-mutant S112K (2.65 mg assuming 3 free binding sites) was dissolved in buffer 1 (1.195 ml), 
and Ir-stock solution was added (12.1 µl).  
Sample without SAV mutant (intermediate solutions): buffer 1 (0.495 ml) and Ir-stock solution 
was added (5 µl). Mixing was achieved by means of a vortex mixer. Reaction set up: To buffer 1 
(125 µL) was added buffer 2 (250 µl; final concentration of   
2
HCOONa = 100 mM), ATHase (or 
intermediate solutions) (100 µl, final concentration of Ir = 20 µM) and NAD
+
-stock solution (25 
µl, final concentration = 500 µM). 
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The reaction was incubated and agitated at 30 °C and 200 rpm for 24 h by means of a 
Thermomixer (HLC Biotech Model MHR 23). 
Subsequently D2O (50 µl) was added and the NMR spectra recorded. 
 
Electronic Supplementary Information (ESI) available: 
1
H NMR spectra with water suppression 
and selective 
1
H-TOCSY NMR spectra. 
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